Endothelial dysfunction as a possible link between C-reactive protein levels and cardiovascular disease

Clinical Science

Volumn 98, Issue 5, 2000, Pages 531-535

  Cleland, Stephen J ^a   Sattar, Naveed ^b,d   Petrie, John R ^a   Forouhi, Nita G ^c   Elliott, Henry L ^a   Connell, John M C ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b NHS GREATER GLASGOW AND CLYDE   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d Univ Dept of Pathol Biochemistry   (United Kingdom)

Author keywords

C reactive protein; Endothelial dysfunction; Inflammation; Nitric oxide

Indexed keywords

C REACTIVE PROTEIN; LEPTIN; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NORADRENALIN; VASOCONSTRICTOR AGENT;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CELL ACTIVATION; CHRONIC INFLAMMATION; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE ASSOCIATION; ENDOTHELIUM CELL; HUMAN; HUMAN EXPERIMENT; MEAN ARTERIAL PRESSURE; MULTIVARIATE ANALYSIS; NORMAL HUMAN; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

EID: 0034016962     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs0980531     Document Type: Article

References (17)

1. 1 Ross, R. (1999) Atherosclerosis - an inflammatory disease. N. Engl. J. Med. 340, 115-126
2. 2 Mendall, M. A. (1998) Inflammatory responses and coronary heart disease. Br. Med. J. 316, 953-954
3. 3 Haverkate, F., Thompson, S. G., Pyke, S. D. M., Gallimore, J. R. and Pepys, M. M. (1997) Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet 349, 426-466
4. 4 Ridker, P., Cushman, M., Stampfer, M., Tracy, R. and Hennekens, C. (1997) Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men. N. Engl. J. Med. 336, 973-979
5. 5 Kluft, C., de Maat, M. P. M., Gevers Leuven, J. A., Potter van Loon, B. J. and Mohrschladt, M. F. (1999) Statins and C-reactive protein. Lancet 353, 1274
6. 6 Bhagat, K. and Vallance, P. (1997) Inflammatory cytokines impair endothelium-dependent dilatation in human veins in vivo. Circulation 96, 3042-3047
7. 7 Bhagat, K., Moss, R., Collier, J. and Vallance, P. (1996) Endothelial 'stunning' following a brief exposure to endotoxin: a mechanism to link infection and infarction? Cardiovasc. Res. 32, 822-829
8. 8 Vallance, P., Collier, J. and Bhagat, K. (1997) Infection, inflammation, and infarction: does acute endothelial dysfunction provide a link? Lancet 349, 1391-1392
9. 9 Schalkwijk, C. G., Poland, D. C., van Dijk, W. et al. (1999) Plasma concentration of C-reactive protein is increased in type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation. Diabetologia 42, 351-357
10. 10 Yudkin, J. S., Stehouwer, C. D. A., Emeis, J. J. and Coppack, S. W. (1999) C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction - a potential role for cytokines originating from adipose tissue? Arterioscler. Thromb. Vasc. Biol. 19, 972-978
11. 11 Lipid Research Clinics Program. (1975) Lipid and Lipoprotein Analysis. In Lipid Research Clinics Program Manual of Laboratory Operations, vol. 1., p. 75, DHEW Publications (NIH), Bethesda, MD
12. 12 Petrie, J. R., Ueda, S., Webb, D. J., Elliot, H. L. and Connell, J. M. C. (1996) Endothelial nitric oxide production and insulin sensitivity: a physiological link with implications for pathogenesis of cardiovascular disease. Circulation 93, 1331-1333
13. 13 Caro, J. F., Sinha, M. K., Kolaczynski, J. W., Zhang, P. L. and Considine, R. V. (1996) Leptin: the tale of an obesity gene. Diabetes 45, 1455-1462
14. 14 Mohamed-Ali, V., Pinkney, J. H. and Coppack, S. W. (1998) Adipose tissue as an endocrine and paracrine organ. Int. J. Obesity 22, 1145-1158
15. 15 Steínberg, H. O., Chaker, H., Leaming, R., Johnson, A., Brechtel, G. and Baron, A. D. (1996) Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J. Clin. Invest. 97, 2601-2610
16. 16 Hashimoto, M., Akishita, M., Eto, M. et al. (1998) The impairment of flow-mediated vasodilatation in obese men with visceral fat accumulation. Int. J. Obesity Relat. Metab. Disorders 22, 477-484
17. 17 Yoshizumi, M., Perrella, M. A., Burnett, Jr., J. C. and Lee, M. E. (1993) Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circ. Res. 73, 205-209